Moderna says the Food and Drug Administration has decided to delay its ruling on authorizing the drugmaker's coronavirus vaccine for children ages 12 to 17 so it can further study any connection to heart inflammation.
The post Moderna Says FDA Delaying Decision on COVID Vaccine for Kids appeared first on The Washington Informer.
